Elevance Health, Inc. Common Stock (NY:ELV)

391.79 +5.36 (+1.39%)

Delayed Quote Updated: 12:48 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Elevance Health, Inc. Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

28 29 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 12, 2024

Via Benzinga

Elevance Health’s Whole Health Index Demonstrates Opportunity to Improve Health

August 12, 2024

From Elevance Health, Inc.

Via Business Wire

$1000 Invested In This Stock 20 Years Ago Would Be Worth $13,000 Today ↗

August 07, 2024

Via Benzinga

Elevance Health Teams Up with the Impact Fitness Foundation to Support Irvington Preparatory Academy

July 31, 2024

From Elevance Health, Inc.

Via Business Wire

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $10,000 Today ↗

July 25, 2024

Via Benzinga

How Is The Market Feeling About Elevance Health? ↗

July 23, 2024

Via Benzinga

A Closer Look at Elevance Health's Options Market Dynamics ↗

July 18, 2024

Via Benzinga

Leading Healthcare Provider Stock Soars on Earnings Beat

July 26, 2024

Molina Healthcare's Q2 earnings and strategic acquisitions fuel a surge in its stock price, signaling the potential for continued growth.

Via MarketBeat

Topics Earnings

Is This Telehealth Stock a Buy After the Recent Pullback?

July 19, 2024

Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.

Via MarketBeat

BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations ↗

July 18, 2024

Elevance Health reports Q2 revenues of $43.2 billion, slightly above consensus despite a 0.4% YoY decline driven by Medicaid membership attrition. Analysts express concerns over ongoing Medicaid margin...

Via Benzinga

Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration ↗

July 17, 2024

Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks among health insurers.

Via Benzinga

Topics Government

Evaluating Elevance Health: Insights From 15 Financial Analysts ↗

July 15, 2024

Via Benzinga

If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,100 Today ↗

July 08, 2024

Via Benzinga

Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What's Driving Markets Wednesday? ↗

July 17, 2024

It’s deep red on Wall Street on Wednesday, with tech stocks sharply falling amid a semiconductor broad-based selloff following news that the Biden administration is hastening export restrictions to...

Via Benzinga

Elevance Health (ELV) Q2 2024 Earnings Call Transcript ↗

July 17, 2024

ELV earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance ↗

July 17, 2024

Elevance Health surpasses Q2 profit and revenue estimates, reporting $43.2 billion in revenue and $2.3 billion in profit. Despite a 5% decline in medical membership due to Medicaid attrition, premium...

Via Benzinga

16 Analysts Have This To Say About Elevance Health ↗

June 24, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 10 Years ↗

June 20, 2024

Via Benzinga

Elevance Health Reports Second Quarter 2024 Results

July 17, 2024

From Elevance Health, Inc.

Via Business Wire

3 Stocks to Buy From the ‘Ultimate’ Buy-and-Hold Portfolio ↗

July 08, 2024

Finding stocks to buy and hold for the long haul is sometimes as easy as grabbing a few suggestions from a seasoned investment pro.

Via InvestorPlace

Elevance Health Releases Impact Report

July 08, 2024

From Elevance Health, Inc.

Via Business Wire

Tame Volatility With These 3 Low Beta Stocks ↗

July 06, 2024

Beta measures a stock's volatility in comparison to the overall market. Three low-beta stocks could all be considered for those looking for a more conservative approach.

Via Talk Markets

Elevance Stock Elevated On Excellent Marketing Execution ↗

June 27, 2024

Elevance stock boasts a 92 EPS Rating out of 99. It has an 86 Composite Rating and a B+ Accumulation/Distribution Rating.

Via Investor's Business Daily

Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2024 Results on July 17, 2024

June 26, 2024

From Elevance Health, Inc.

Via Business Wire

Morgan Stanley Says Elevance Health's Growth Attributed To Consistent Performance But Undervalued ↗

June 24, 2024

Morgan Stanley initiates coverage on Elevance Health with an Overweight rating and a $643 price target. Elevance Health's diversified offerings and growth potential in Medicare Advantage, PBM,...

Via Benzinga

The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits ↗

June 23, 2024

Explore three top growth-ready healthcare stocks to buy amid rising demand for healthcare services globally.

Via InvestorPlace

3 Healthcare Stocks to Buy as Medicare Goes Private ↗

June 19, 2024

The privatization of Medicare makes these three healthcare stocks to buy worthy of consideration for your portfolio.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

June 19, 2024

Via Benzinga

10 Value Stocks With Low Debt And Strong Growth ↗

June 14, 2024

One of the problems we are facing as a value investor is an extremely high stock market and an aberrantly long-running bull market. It’s one of the longest in recorded history.

Via Talk Markets

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

June 07, 2024

The Benzinga Stock Whisper Index highlights five stocks that are seeing increased interest from readers during the week.

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.